On july 8, 2020, mentor became aware that following information was inadvertently not reported or incorrectly reported under the previous initial submission on september 6, 2017.
The information has been corrected on this form.
(b)(4).
Reason for device explant and/or reoperation: right side anaplastic large-cell lymphoma manufacturer¿s reference number: (b)(4).
|
No device was received for analysis at the time of submission of the initial 3500a.
since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.
As such, the investigation will be closed.
If the complaint device is received in the future, we will reopen the complaint and perform the investigation as appropriate.
The device history record (dhr) of lot number 6871997 was reviewed and no anomalies were found related to this complaint.
In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.
(b)(4).
|
It was reported by a physician that a (b)(6) year old female patient was diagnosed with alcl on (b)(6) 2017.
This patient¿s medical history includes diagnosis of left breast invasive ductal carcinoma in (b)(6) 2015.
She underwent bilateral mastectomy and bilateral tissue expander placement in (b)(6) 2015.
The patient had mentor tissue expanders that were implanted from (b)(6) 2015.
The patient then had mentor memory shape low high moderate plus profile breast implants (catalog #334-1507, r.
Side serial # (b)(4)) implanted in (b)(6) 2015.
On (b)(6) 2017, the patient experienced a large right breast effusion that developed over 24-48 hours.
The effusion was aspirated and tested using flow cytometry and cd30 ihc and came back positive for bia-alcl on (b)(6) 2017.
The time between patient signs/symptoms of peri-implant alcl to definitive diagnosis was 1 week.
The patient did not have any complications such as infection, hematoma, or implant rotation during implant course prior to alcl diagnosis.
The patient did not experience skin lesions, fevers, night sweats or weight loss.
There was no pain, redness, palpable breast mass, or capsular contracture.
The lymphoma cells were found in the seroma fluid surrounding the implant.
Immunohistochemical and flow cytometry testing showed alk negative and cd30 positive results.
This is a pathologically confirmed stage ie primary diagnosis of alcl.
Based on histology, there is no capsular involvement.
The lymphoma cells were found in the effusion fluid surrounding the implant.
The patient underwent bilateral implant removal and capsulectomies with no implant replacement on (b)(6) 2017.
The implants were intact and not ruptured upon removal.
|